Both in Pharmaceuticals
TherapeuticsMD vs Seres Therapeutics
Over the past year TXMD returned +39.5% and MCRB returned −88.3%; their daily moves had a correlation of -0.06.
TXMD +39.5% MCRB −88.3%Growth of $1, one year, split-adjusted
| Metric | TXMD | MCRB |
|---|---|---|
| Price | $1.80 | $2.09 |
| Market cap | $20.8M | $21.0M |
| Today | −2.70% | −1.88% |
| 1 month | −15.5% | −42.3% |
| 6 months | −17.8% | −74.2% |
| Year to date | +10.4% | −86.0% |
| 1 year | +47.5% | −88.5% |
| Revenue growth (YoY) | −8.7% | — |
| Gross margin | 100.0% | 100.0% |
| Net margin | 17.8% | 622.4% |
| P/E (TTM) | — | — |
| Price / sales | 6.4× | 11.1× |
| Net cash | $9.2M | $15.6M |
| Dividend yield | — | — |
| Volatility (60d) | 33.4% | 65.5% |
| Short % of float | 0.2% | 4.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).